
Siponimod Could Improve Cognition in Advanced Multiple Sclerosis
A new multiple sclerosis (MS) drug, siponimod, significantly improves cognition for patients with advanced disease, new research shows. VulcanChem PASADENA, CALIFORNIA, UNITED STATES, December 22, 2020 /EINPresswire.com/ -- People with the advanced form …